Physician profile
Michael J Gault
NPI 1598857930
$32,202.56
in general payments reported to CMS, 2019-2025
58 companies · $5,116 in 2025
The $5,116 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,365 · 2021: $3,310 · 2022: $3,842 · 2023: $3,236 · 2024: $3,438 · 2025: $5,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $6.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,783.11 |
| Travel and Lodging | $6.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,278.97 | 2019-2020 | |
| Medtronic, INC. | $2,780.33 | 2021-2025 | Corevalve Evolut R, Micra, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $2,728.41 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System, Rotapro |
| Biotronik INC. | $2,176.75 | 2019-2025 | Amvia Edge, Orsiro Mission, Biomonitor |
| Amgen INC. | $1,554.65 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,387.34 | 2019-2025 | |
| Aop Health US, LLC | $1,290.39 | 2025 | Rapiblyk |
| Penumbra, INC. | $1,129.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $885.87 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $746.08 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $731.58 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $670.13 | 2019-2024 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $656.86 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $619.88 | 2019-2025 | Jardiance |
| Pfizer INC. | $600.06 | 2019-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $589.91 | 2022-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $573.57 | 2022-2025 | Amvuttra |
| Abbott Laboratories | $555.96 | 2019-2024 | Navitor, Perclose Prostyle, Jot Dx |
| Janssen Pharmaceuticals, INC | $436.01 | 2019-2024 | Xarelto |
| Scpharmaceuticals INC. | $400.63 | 2023-2025 | |
| Stryker Corporation | $385.67 | 2025 | Flowtriever, Flowstasis, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $366.69 | 2022-2025 | Ozempic, Wegovy |
| Esperion Therapeutics, INC. | $348.09 | 2020-2025 | Nexletol, Nexlizet |
| Astellas Pharma US INC | $341.48 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $334.88 | 2019-2021 | |
| Amarin Pharma, INC. | $330.42 | 2019-2021 | |
| Shockwave Medical, INC | $293.82 | 2022 | |
| Abiomed | $276.18 | 2019-2025 | Impella |
| Kiniksa Pharmaceuticals International, Plc | $255.56 | 2024 | Arcalyst |
| Cvrx, INC. | $249.28 | 2021-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $223.91 | 2020-2024 | Wainua |
| Inari Medical, INC. | $207.24 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $156.98 | 2019-2025 | Kengreal |
| Arbor Pharmaceuticals, INC. | $151.80 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $131.65 | 2021-2023 | Arcalyst |
| Tactile Systems Technology INC | $123.65 | 2020-2025 | Nimbl, Flexitouch Plus |
| Actelion Pharmaceuticals US, INC. | $123.17 | 2023-2025 | Uptravi, Opsumit |
| Atricure, INC. | $103.36 | 2022-2025 | Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $98.56 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Otsuka America Pharmaceutical, INC. | $94.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.87 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $91.18 | 2023-2025 | Assure Wcd |
| Altathera Pharmaceuticals LLC | $87.83 | 2024-2025 | Sotalol Hydrochloride |
| Azurity Pharmaceuticals, INC. | $79.13 | 2023-2025 | Edarbi, Edarbi |
| Davol INC. | $62.21 | 2022 | |
| Celgene Corporation | $62.12 | 2023 | Camzyos |
| Gilead Sciences, INC. | $59.53 | 2019 | |
| Bridgebio Pharma, INC. | $49.96 | 2025 | Attruby |
| Cardiovascular Systems INC. | $48.49 | 2019-2020 | |
| Preventice Services, LLC | $31.93 | 2021 | |
| Cleerly, INC. | $27.82 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Ani Pharmaceuticals, INC. | $24.14 | 2024 | Purified Cortrophin Gel |
| Lantheus Medical Imaging, INC. | $20.15 | 2022 | |
| Corcept Therapeutics | $19.73 | 2025 | Korlym |
| Irhythm Technologies, INC. | $14.55 | 2024 | Zio Xt Patch, Zio Monitor |
| Lundbeck LLC | $14.26 | 2020 | |
| Philips North America LLC | $13.93 | 2025 | Ice 3d |
| Itamar Medical INC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.